scholarly article | Q13442814 |
P356 | DOI | 10.1136/BMJ.1.6117.875 |
P953 | full work available at URL | https://europepmc.org/articles/PMC1603699 |
https://europepmc.org/articles/PMC1603699?pdf=render | ||
https://syndication.highwire.org/content/doi/10.1136/bmj.1.6117.875 | ||
P932 | PMC publication ID | 1603699 |
P698 | PubMed publication ID | 638504 |
P5875 | ResearchGate publication ID | 22502811 |
P2093 | author name string | L. Wide | |
S. J. Nillius | |||
T. Bergh | |||
P2860 | cites work | Double point test with the Goldmann perimeter | Q67430747 |
Conservative management of a pituitary tumor during pregnancy following induction of ovulation with gonadotropins | Q67541232 | ||
Management of hyperprolactinaemic amenorrhoea | Q67583331 | ||
Plasma prolactin changes during the administration of human menopausal gonadotropins in nonovulatory women | Q67669813 | ||
Galactrorrhoea, hyperprolactinaemia and pituitary tumours in the female | Q67785187 | ||
[Emergency hypophysectomy during the 2d month of pregnancy after inducing ovulation] | Q69385818 | ||
Radioimmunoassays employing immunosorbents | Q70128009 | ||
Ergot-induced inhibition of pituitary tumor growth in rats | Q70373543 | ||
Transient Bitemporal Hemianopsia During Pregnancy After Treatment of Galactorrhea-Amenorrhea Syndrome with Bromocriptine | Q28330320 | ||
Transsphenoidal hypophysectomy | Q33277580 | ||
Pituitary tumour treated by pituitary implantation of yttrium 90 during or before pregnancy (two cases) | Q35141701 | ||
Visual failure from pituitary and parasellar tumours occurring with favourable outcome in pregnant women | Q37038474 | ||
Prevalence and presentation of hyperprolactinaemia in patients with "functionless" pituitary tumours | Q39429295 | ||
Radiological aspects of pituitary—Hypothalamic disease | Q39661184 | ||
Hyperprolactinaemia in amenorrhoea - incidence and clinical significance | Q40824786 | ||
Nonpuerperal galactorrhea and hyperprolactinemia. Clinical findings, endocrine features and therapeutic responses in 56 cases | Q42440784 | ||
Clinical and endocrine features of hyperprolactinaemic amenorrhoea | Q42443937 | ||
Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells | Q44151531 | ||
Pregnancy in patients with pituitary tumors | Q44441829 | ||
Variation in LH and FSH response to LH-releasing hormone during the menstrual cycle | Q44996422 | ||
Pregnancy following bromocryptine therapy for the amenorrhoea-galactorrhoea syndrome due to a pituitary tumour | Q45909524 | ||
Serum prolactin levels and the value of bromocriptine in the treatment of anovulatory infertility | Q46081330 | ||
Galactorrhea: a study of 235 cases, including 48 with pituitary tumors | Q48306540 | ||
Suppression of pituitary tumor growth and function by ergot alkaloids | Q48669061 | ||
Morphology of the lactotropes and somatotropes of man and rhesus monkeys | Q48764190 | ||
Effect of pregnancy on the somatotroph and the prolactin cell of the human adenohypophysis | Q48964398 | ||
Sarcoma: a possible late result of effective radiation therapy for pituitary adenoma. Report of two cases. | Q51235748 | ||
BRAIN NECROSIS AFTER IRRADIATION OF THE HYPOPHYSIS IN CUSHING'S DISEASE. | Q51274026 | ||
Delayed radionecrosis of the brain following therapeutic x-radiation of the pituitary. | Q51303698 | ||
Influence of pregnancy on visual fields in suprasellar tumors. | Q51305558 | ||
Two cerebral complications of pregnancy: brain tumor, and spontaneous subarachnoid hemorrhage. | Q51339204 | ||
Visual disturbance in pregnancy after induction of ovulation | Q55153394 | ||
Emergency hypophysectomy in pregnancy after induction of ovulation | Q55288900 | ||
Prolactin studies in "functionless" pituitary tumours | Q66894538 | ||
Incidence and significance of hyperprolactinaemia in women with amenorrhea | Q66902611 | ||
Detection, evaluation, and treatment of pituitary microadenomas in patients with galactorrhea and amenorrhea | Q67012078 | ||
Induction of ovulation in infertile women with pituitary tumors | Q67284605 | ||
Bromocriptine treatment of female infertility: report of 13 pregnancies | Q67352733 | ||
P433 | issue | 6117 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | engineering | Q11023 |
human pregnancy | Q11995 | ||
P304 | page(s) | 875-880 | |
P577 | publication date | 1978-04-01 | |
1978-04-08 | |||
P1433 | published in | The BMJ | Q546003 |
P1476 | title | Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumors | |
Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumours | |||
P478 | volume | 1 |
Q67019706 | A practical approach for the evaluation of women with abnormal polytomography or elevated prolactin levels |
Q39566389 | AFP and hCG as tumor markers in therapy of malignant germ cell tumors |
Q66700662 | Bromocriptine in pituitary tumours |
Q66701518 | Bromocriptine, pituitary tumours, and pregnancy |
Q71359620 | Bromocriptine-induced regression of a suprasellar extending prolactinoma during pregnancy |
Q71837536 | CT follow-up of microprolactinomas during bromocriptine-induced pregnancy |
Q41623403 | Clinical Findings and Testicular Histology in Three Hyperprolactinemic Infertile Men |
Q72418454 | Clinical course and outcome of pregnancy in twenty-five patients with pituitary microadenomas |
Q71158287 | Clinical course and outcome of thirty-five pregnancies in infertile hyperprolactinemic women |
Q40730522 | Complications of assisted reproductive techniques. |
Q95794039 | HCG in patients with hydatidiform mole or chorionepithelioma |
Q66700661 | Hand-mirror cells in T-cell lymphoma |
Q42446070 | Heterogeneity of prolactin responses to oestradiol benzoate in women with prolactinomas |
Q44510933 | High-dose melphalan and cyclophosphamide pre-treatment |
Q40982203 | Human prolactin (author's transl) |
Q36660118 | Hyperprolactinaemia--investigation and results of treatment |
Q95793927 | Hyperprolactinemia and sterility |
Q40623716 | Investigation and Management of Symptomatic Hyperprolactinaemia |
Q53753317 | Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine. |
Q72481062 | Lergotrile, Pregnancy, and Galactorrhea-Amenorrhea |
Q83611051 | Management of pituitary tumors in pregnancy |
Q35098756 | Medical management of pituitary adenomas: the special case of management of the pregnant woman |
Q35071904 | PRL-secreting pituitary adenomas in pregnancy |
Q70798822 | Partial remission of hyperprolactinemic amenorrhea after bromocriptine-induced pregnancy |
Q70868534 | Pituitary function in prolactinoma. Effect of surgery and postoperative bromocriptine therapy |
Q34517568 | Pituitary tumours during pregnancy in mothers treated with bromocriptine |
Q66955324 | Pregnancies in women with hyperprolactinaemia: clinical course and obstetric complications of 41 pregnancies in 27 women |
Q71301348 | Pregnancy in an acromegalic after bromocriptine therapy |
Q70353965 | Pregnancy in hyperprolactinemic women |
Q66979379 | Pregnancy in patients presenting with hyperprolactinaemia |
Q70681794 | Prolactin and reproduction |
Q70673692 | Prolactin-secreting pituitary adenomas: neurosurgical management of 37 patients |
Q39799072 | Prolactin: role in health and disease |
Q42359810 | Prolactinoma: a question of rational treatment |
Q69937240 | Prolactinomas |
Q69940280 | Prolactinomas |
Q82254848 | Prolactinomas and pregnancy |
Q42257561 | Rapid regression of a suprasellar extending prolactinoma after bromocriptine treatment during pregnancy |
Q67428513 | Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine |
Q53796549 | Return of menstruation and normalization of prolactin in hyperprolactinemic women with bromocriptine-induced pregnancy. |
Q40989384 | Serum prolactin and gonadotrophin levels before and after luteinizing hormone-releasing hormone in the investigation of amenorrhoea |
Q43961444 | Successful Outcome of Ergocryptine-Induced Pregnancies in Twenty-One Women with Prolactin-Secreting Pituitary Adenomas |
Q41043627 | Surgical treatment of prolactin-secreting microadenomas |
Q70576304 | Teratogenicity of bromocryptine in pregnant rats |
Q39545272 | Tests of prolactin secretion in diagnosis of prolactinomas |
Q39665203 | The Incidence of Complications During Pregnancy after Treatment of Hyperprolactinemia with Bromocriptine in Patients with Radiologically Evident Pituitary Tumors |
Q71085614 | The management of prolactin-secreting pituitary tumors |
Q72636435 | The mode of action of bromocriptine |
Q40283167 | The use of bromocriptine in obstetrics and gynecology. |
Q39554929 | Therapeutic applications of bromocriptine in endocrine and neurological diseases |
Q42462457 | Two-year treatment with oral contraceptives in hyperprolactinemic patients. |
Q39799055 | Use of Bromocriptine in Hyperprolactinaemic Anovulation and Related Disorders |